ARCHIVES

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

This article is from The Cancer Letter archive.

Vol. 03 No. 01 | January 7, 1977

Download PDF Visit The Full Archive

Related Articles

Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research

November 15, 1996

Congress Passes NIH Reauthorization.

December 15, 2006

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

December 25, 2009

Small Study: Radiation, Chemo May Better Control Anal Cancer

November 26, 2010

Healy Comes To Defense Of NCI’s Robert Wittes; Official Has Been Target Of Innuendo Over Taxo

September 11, 1992

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005